Literature DB >> 13314153

The effect of sodium 2-phenylbutyrate in experimental atherosclerosis.

D KRITCHEVSKY, A W MOYER, W C TESAR, R F MCCANDLESS, J B LOGAN, R A BROWN, M ENGLERT.   

Abstract

Entities:  

Keywords:  ARTERIOSCLEROSIS/experimental; BUTYRATES/effects

Mesh：

Substances：

Year:  1956        PMID： 13314153     DOI： 10.1177/000331975600700205

Source DB:  PubMed          Journal:  Angiology        ISSN： 0003-3197            Impact factor:   3.619


× No keyword cloud information.
  1 in total

1.  Phase I dose escalation clinical trial of phenylbutyrate sodium administered twice daily to patients with advanced solid tumors.

Authors:  Luis H Camacho; Jon Olson; William P Tong; Charles W Young; David R Spriggs; Mark G Malkin
Journal:  Invest New Drugs       Date:  2006-10-20       Impact factor: 3.850
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.